These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 35173095)

  • 1. In vivo Human MR Spectroscopy Using a Clinical Scanner: Development, Applications, and Future Prospects.
    Tomiyasu M; Harada M
    Magn Reson Med Sci; 2022 Mar; 21(1):235-252. PubMed ID: 35173095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and applications of in vivo clinical magnetic resonance spectroscopy.
    Cox IJ
    Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton MRS and MRSI of the brain without water suppression.
    Dong Z
    Prog Nucl Magn Reson Spectrosc; 2015 Apr; 86-87():65-79. PubMed ID: 25919199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9.
    Drost DJ; Riddle WR; Clarke GD;
    Med Phys; 2002 Sep; 29(9):2177-97. PubMed ID: 12349940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological consensus on clinical proton MRS of the brain: Review and recommendations.
    Wilson M; Andronesi O; Barker PB; Bartha R; Bizzi A; Bolan PJ; Brindle KM; Choi IY; Cudalbu C; Dydak U; Emir UE; Gonzalez RG; Gruber S; Gruetter R; Gupta RK; Heerschap A; Henning A; Hetherington HP; Huppi PS; Hurd RE; Kantarci K; Kauppinen RA; Klomp DWJ; Kreis R; Kruiskamp MJ; Leach MO; Lin AP; Luijten PR; Marjańska M; Maudsley AA; Meyerhoff DJ; Mountford CE; Mullins PG; Murdoch JB; Nelson SJ; Noeske R; Öz G; Pan JW; Peet AC; Poptani H; Posse S; Ratai EM; Salibi N; Scheenen TWJ; Smith ICP; Soher BJ; Tkáč I; Vigneron DB; Howe FA
    Magn Reson Med; 2019 Aug; 82(2):527-550. PubMed ID: 30919510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a fused phantom for quantitative evaluation of brain metabolites and enhanced quality assurance testing for magnetic resonance imaging and spectroscopy.
    Song KH; Kim SY; Lee DW; Jung JY; Lee JH; Baek HM; Choe BY
    J Neurosci Methods; 2015 Nov; 255():75-84. PubMed ID: 26277420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musculoskeletal spectroscopy.
    Boesch C
    J Magn Reson Imaging; 2007 Feb; 25(2):321-38. PubMed ID: 17260389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton MR spectroscopy of the prostate.
    Mueller-Lisse UG; Scherr MK
    Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on MR Spectroscopy in Cancer Management: Advances in Instrumentation, Acquisition, and Analysis.
    Martinez Luque E; Liu Z; Sung D; Goldberg RM; Agarwal R; Bhattacharya A; Ahmed NS; Allen JW; Fleischer CC
    Radiol Imaging Cancer; 2024 May; 6(3):e230101. PubMed ID: 38578207
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Aida N
    Magn Reson Med Sci; 2022 Mar; 21(1):9-28. PubMed ID: 34421092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-nuclear MRS and MRI on a standard clinical proton-only MRI scanner.
    Yen YF; Takahashi AM; Ackerman JL
    J Magn Reson Open; 2023 Dec; 16-17():. PubMed ID: 38046796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR-Nucleomics: The study of pathological cellular processes with multinuclear magnetic resonance spectroscopy and imaging in vivo.
    Sun P; Wu Z; Lin L; Hu G; Zhang X; Wang J
    NMR Biomed; 2023 Feb; 36(2):e4845. PubMed ID: 36259659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac
    Gupta A
    Heart Fail Rev; 2023 Mar; 28(2):485-532. PubMed ID: 36427161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate timing of proton MR spectroscopy in breast cancer.
    Tozaki M
    Magn Reson Med Sci; 2011; 10(2):71-7. PubMed ID: 21720108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The INTERPRET Decision-Support System version 3.0 for evaluation of Magnetic Resonance Spectroscopy data from human brain tumours and other abnormal brain masses.
    Pérez-Ruiz A; Julià-Sapé M; Mercadal G; Olier I; Majós C; Arús C
    BMC Bioinformatics; 2010 Nov; 11():581. PubMed ID: 21114820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo magnetic resonance spectroscopy of liver tumors and metastases.
    ter Voert EG; Heijmen L; van Laarhoven HW; Heerschap A
    World J Gastroenterol; 2011 Dec; 17(47):5133-49. PubMed ID: 22215937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular aspects of magnetic resonance imaging and spectroscopy.
    Boesch C
    Mol Aspects Med; 1999; 20(4-5):185-318. PubMed ID: 10643589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of machine learning applications for the proton MR spectroscopy workflow.
    van de Sande DMJ; Merkofer JP; Amirrajab S; Veta M; van Sloun RJG; Versluis MJ; Jansen JFA; van den Brink JS; Breeuwer M
    Magn Reson Med; 2023 Oct; 90(4):1253-1270. PubMed ID: 37402235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical magnetic resonance spectroscopy: a critical evaluation.
    Lenkinski RE
    Invest Radiol; 1989 Dec; 24(12):1034-8. PubMed ID: 2606632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.